Parmar Kush sold TRDA

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001664281-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Aug 10, 2026

Published

Aug 10, 2026

Ingested by INSIDER

Nov 5, 02:24 UTC

Last re-read

Nov 5, 02:24 UTC

Extracted facts

Filer

Parmar Kush

Role

Director

Transaction

Open-market saleAs filed: “S”

Asset

Entrada Therapeutics, Inc.

Ticker

TRDA

Shares

92.4K

Price per share

$7

Value

$647,108

Execution date (reported)

Aug 10, 2026

Owned after transaction

2.69M shares

Days from execution to publication

0

Calculation

What this establishes

Parmar Kush filed this Form 4 reporting a open-market sale of TRDA on Aug 10, 2026. It became public on Aug 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Parmar Kushcik:0001664281

Issuer

Entrada Therapeutics, Inc.cik:0001689375

Revision history · 0

No field has changed since this record was first ingested.